Parimer Scientific
Private Company
Funding information not available
Overview
Parimer Scientific is a lean, privately-owned CDMO based in San Diego, California, that provides end-to-end development and manufacturing services for novel chemical entities, APIs, and liquid medical devices. It differentiates itself through a client-centric model that includes potential equity-for-services arrangements, waiving IP rights developed under contract, and a focus on navigating complex FDA and ICH regulatory pathways. With a core team of PhD scientists, the company supports clients from preclinical R&D through clinical trials and commercial manufacturing, targeting the need for agile, U.S.-based manufacturing partners in the biotech and pharmaceutical sectors.
Technology Platform
Integrated CDMO services for chemical process development, cGMP API manufacturing, and regulatory support for drug substances and liquid medical devices.
Opportunities
Risk Factors
Competitive Landscape
Parimer competes against large, global CDMOs (e.g., Lonza, Catalent) and other small-to-mid-sized U.S. CDMOs. It differentiates through its lean, scientist-led model, flexibility in deal structures (equity), and explicit waiver of client IP rights. Its focus on early-stage companies and U.S. manufacturing is a key competitive positioning against lower-cost offshore providers.